Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 325 to 332 of 332 entries
Sorted by: Best Match Show Resources per page
Filling the gap: A thorough investigation for the genetic diagnosis of unsolved polyposis patients with monoallelic MUTYH pathogenic variants.

Molecular genetics & genomic medicine

Dell'Elice A, Cini G, Fornasarig M, Armelao F, Barana D, Bianchi F, Casalis Cavalchini GC, Maffè A, Mammi I, Pedroni M, Percesepe A, Sorrentini I, Tibiletti M, Maestro R, Quaia M, Viel A.
PMID: 34704405
Mol Genet Genomic Med. 2021 Dec;9(12):e1831. doi: 10.1002/mgg3.1831. Epub 2021 Oct 26.

BACKGROUNDS: MUTYH-associated polyposis (MAP) is an autosomal recessive disease caused by biallelic pathogenic variants (PV) of the MUTYH gene. The aim of this study was to investigate the genetic causes of unexplained polyposis patients with monoallelic MUTYH PV. The...

Cite
Dell'Elice A, Cini G, Fornasarig M, et al. Filling the gap: A thorough investigation for the genetic diagnosis of unsolved polyposis patients with monoallelic MUTYH pathogenic variants. Mol Genet Genomic Med. 2021;9(12):e1831doi: 10.1002/mgg3.1831.
Dell'Elice, A., Cini, G., Fornasarig, M., Armelao, F., Barana, D., Bianchi, F., Casalis Cavalchini, G. C., Maffè, A., Mammi, I., Pedroni, M., Percesepe, A., Sorrentini, I., Tibiletti, M., Maestro, R., Quaia, M., & Viel, A. (2021). Filling the gap: A thorough investigation for the genetic diagnosis of unsolved polyposis patients with monoallelic MUTYH pathogenic variants. Molecular genetics & genomic medicine, 9(12), e1831. https://doi.org/10.1002/mgg3.1831
Dell'Elice, Anastasia, et al. "Filling the gap: A thorough investigation for the genetic diagnosis of unsolved polyposis patients with monoallelic MUTYH pathogenic variants." Molecular genetics & genomic medicine vol. 9,12 (2021): e1831. doi: https://doi.org/10.1002/mgg3.1831
Dell'Elice A, Cini G, Fornasarig M, Armelao F, Barana D, Bianchi F, Casalis Cavalchini GC, Maffè A, Mammi I, Pedroni M, Percesepe A, Sorrentini I, Tibiletti M, Maestro R, Quaia M, Viel A. Filling the gap: A thorough investigation for the genetic diagnosis of unsolved polyposis patients with monoallelic MUTYH pathogenic variants. Mol Genet Genomic Med. 2021 Dec;9(12):e1831. doi: 10.1002/mgg3.1831. Epub 2021 Oct 26. PMID: 34704405.
Copy Download .nbib Format: NLM
Filling the gap: A thorough investigation for the genetic diagnosis of unsolved polyposis patients with monoallelic MUTYH pathogenic variants.

Molecular genetics & genomic medicine

Dell'Elice A, Cini G, Fornasarig M, Armelao F, Barana D, Bianchi F, Casalis Cavalchini GC, Maffè A, Mammi I, Pedroni M, Percesepe A, Sorrentini I, Tibiletti M, Maestro R, Quaia M, Viel A.
PMID: 34704405
Mol Genet Genomic Med. 2021 Dec;9(12):e1831. doi: 10.1002/mgg3.1831. Epub 2021 Oct 26.

BACKGROUNDS: MUTYH-associated polyposis (MAP) is an autosomal recessive disease caused by biallelic pathogenic variants (PV) of the MUTYH gene. The aim of this study was to investigate the genetic causes of unexplained polyposis patients with monoallelic MUTYH PV. The...

Cite
Dell'Elice A, Cini G, Fornasarig M, et al. Filling the gap: A thorough investigation for the genetic diagnosis of unsolved polyposis patients with monoallelic MUTYH pathogenic variants. Mol Genet Genomic Med. 2021;9(12):e1831doi: 10.1002/mgg3.1831.
Dell'Elice, A., Cini, G., Fornasarig, M., Armelao, F., Barana, D., Bianchi, F., Casalis Cavalchini, G. C., Maffè, A., Mammi, I., Pedroni, M., Percesepe, A., Sorrentini, I., Tibiletti, M., Maestro, R., Quaia, M., & Viel, A. (2021). Filling the gap: A thorough investigation for the genetic diagnosis of unsolved polyposis patients with monoallelic MUTYH pathogenic variants. Molecular genetics & genomic medicine, 9(12), e1831. https://doi.org/10.1002/mgg3.1831
Dell'Elice, Anastasia, et al. "Filling the gap: A thorough investigation for the genetic diagnosis of unsolved polyposis patients with monoallelic MUTYH pathogenic variants." Molecular genetics & genomic medicine vol. 9,12 (2021): e1831. doi: https://doi.org/10.1002/mgg3.1831
Dell'Elice A, Cini G, Fornasarig M, Armelao F, Barana D, Bianchi F, Casalis Cavalchini GC, Maffè A, Mammi I, Pedroni M, Percesepe A, Sorrentini I, Tibiletti M, Maestro R, Quaia M, Viel A. Filling the gap: A thorough investigation for the genetic diagnosis of unsolved polyposis patients with monoallelic MUTYH pathogenic variants. Mol Genet Genomic Med. 2021 Dec;9(12):e1831. doi: 10.1002/mgg3.1831. Epub 2021 Oct 26. PMID: 34704405.
Copy Download .nbib Format: NLM
OPHTHALMIA NEONATORUM in Italy: it is time for change.

Italian journal of pediatrics

Auriti C, Mondì V, Aversa S, Merazzi D, Lozzi S, Petroni S, Baldascino A, Massenzi L, Bellù R, Martinelli S, Mosca F.
PMID: 34922593
Ital J Pediatr. 2021 Dec 18;47(1):238. doi: 10.1186/s13052-021-01186-2.

Ophthalmia neonatorum (ON) refers to any conjunctivitis occurring in the first 28 days of life. In the past Neisseria gonorrhoeae was the most common cause of ON. It decreased with the introduction of prophylaxis at birth with the instillation...

Cite
Auriti C, Mondì V, Aversa S, et al. OPHTHALMIA NEONATORUM in Italy: it is time for change. Ital J Pediatr. 2021;47(1):238doi: 10.1186/s13052-021-01186-2.
Auriti, C., Mondì, V., Aversa, S., Merazzi, D., Lozzi, S., Petroni, S., Baldascino, A., Massenzi, L., Bellù, R., Martinelli, S., & Mosca, F. (2021). OPHTHALMIA NEONATORUM in Italy: it is time for change. Italian journal of pediatrics, 47(1), 238. https://doi.org/10.1186/s13052-021-01186-2
Auriti, Cinzia, et al. "OPHTHALMIA NEONATORUM in Italy: it is time for change." Italian journal of pediatrics vol. 47,1 (2021): 238. doi: https://doi.org/10.1186/s13052-021-01186-2
Auriti C, Mondì V, Aversa S, Merazzi D, Lozzi S, Petroni S, Baldascino A, Massenzi L, Bellù R, Martinelli S, Mosca F. OPHTHALMIA NEONATORUM in Italy: it is time for change. Ital J Pediatr. 2021 Dec 18;47(1):238. doi: 10.1186/s13052-021-01186-2. PMID: 34922593.
Copy Download .nbib Format: NLM
HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME).

Applied immunohistochemistry & molecular morphology : AIMM

Grillini M, Ricci C, Pino V, Pedrini S, Fiorentino M, Corti B.
PMID: 34508017
Appl Immunohistochem Mol Morphol. 2022 Jan 01;30(1):14-18. doi: 10.1097/PAI.0000000000000972.

PRAME (PReferentially expressed Antigen in MElanoma) is a tumor-associated antigen that was recently found to be expressed by malignant melanocytic lesions but not by benign ones, thus resulting useful in this diagnostic field. PRAME could also be expressed by...

Cite
Grillini M, Ricci C, Pino V, et al. HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME). Appl Immunohistochem Mol Morphol. 2022;30(1):14-18doi: 10.1097/PAI.0000000000000972.
Grillini, M., Ricci, C., Pino, V., Pedrini, S., Fiorentino, M., & Corti, B. (2022). HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME). Applied immunohistochemistry & molecular morphology : AIMM, 30(1), 14-18. https://doi.org/10.1097/PAI.0000000000000972
Grillini, Marco, et al. "HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME)." Applied immunohistochemistry & molecular morphology : AIMM vol. 30,1 (2022): 14-18. doi: https://doi.org/10.1097/PAI.0000000000000972
Grillini M, Ricci C, Pino V, Pedrini S, Fiorentino M, Corti B. HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME). Appl Immunohistochem Mol Morphol. 2022 Jan 01;30(1):14-18. doi: 10.1097/PAI.0000000000000972. PMID: 34508017.
Copy Download .nbib Format: NLM
A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors.

Oncogene

Di Giulio S, Colicchia V, Pastorino F, Pedretti F, Fabretti F, Nicolis di Robilant V, Ramponi V, Scafetta G, Moretti M, Licursi V, Belardinilli F, Peruzzi G, Infante P, Goffredo BM, Coppa A, Canettieri G, Bartolazzi A, Ponzoni M, Giannini G, Petroni M.
PMID: 34508175
Oncogene. 2021 Oct;40(43):6143-6152. doi: 10.1038/s41388-021-02003-0. Epub 2021 Sep 10.

MYCN drives aggressive behavior and refractoriness to chemotherapy, in several tumors. Since MYCN inactivation in clinical settings is not achievable, alternative vulnerabilities of MYCN-driven tumors need to be explored to identify more effective and less toxic therapies. We previously...

Cite
Di Giulio S, Colicchia V, Pastorino F, et al. A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors. Oncogene. 2021;40(43):6143-6152doi: 10.1038/s41388-021-02003-0.
Di Giulio, S., Colicchia, V., Pastorino, F., Pedretti, F., Fabretti, F., Nicolis di Robilant, V., Ramponi, V., Scafetta, G., Moretti, M., Licursi, V., Belardinilli, F., Peruzzi, G., Infante, P., Goffredo, B. M., Coppa, A., Canettieri, G., Bartolazzi, A., Ponzoni, M., Giannini, G., & Petroni, M. (2021). A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors. Oncogene, 40(43), 6143-6152. https://doi.org/10.1038/s41388-021-02003-0
Di Giulio, Stefano, et al. "A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors." Oncogene vol. 40,43 (2021): 6143-6152. doi: https://doi.org/10.1038/s41388-021-02003-0
Di Giulio S, Colicchia V, Pastorino F, Pedretti F, Fabretti F, Nicolis di Robilant V, Ramponi V, Scafetta G, Moretti M, Licursi V, Belardinilli F, Peruzzi G, Infante P, Goffredo BM, Coppa A, Canettieri G, Bartolazzi A, Ponzoni M, Giannini G, Petroni M. A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors. Oncogene. 2021 Oct;40(43):6143-6152. doi: 10.1038/s41388-021-02003-0. Epub 2021 Sep 10. PMID: 34508175; PMCID: PMC8553625.
Copy Download .nbib Format: NLM
Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy.

Trends in cancer

Petroni G, Kroemer G, Galluzzi L.
PMID: 33518493
Trends Cancer. 2021 Mar;7(3):179-181. doi: 10.1016/j.trecan.2021.01.005. Epub 2021 Jan 29.

Autologous T cells engineered to express a chimeric antigen receptor (CAR) remain poorly effective against solid tumors, partly because solid neoplasms can establish an immunosuppressive microenvironment. Recent findings by Srivastava et al. suggest that immunogenic chemotherapeutics such as oxaliplatin...

Cite
Petroni G, Kroemer G, Galluzzi L. Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy. Trends Cancer. 2021;7(3):179-181doi: 10.1016/j.trecan.2021.01.005.
Petroni, G., Kroemer, G., & Galluzzi, L. (2021). Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy. Trends in cancer, 7(3), 179-181. https://doi.org/10.1016/j.trecan.2021.01.005
Petroni, Giulia, et al. "Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy." Trends in cancer vol. 7,3 (2021): 179-181. doi: https://doi.org/10.1016/j.trecan.2021.01.005
Petroni G, Kroemer G, Galluzzi L. Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy. Trends Cancer. 2021 Mar;7(3):179-181. doi: 10.1016/j.trecan.2021.01.005. Epub 2021 Jan 29. PMID: 33518493.
Copy Download .nbib Format: NLM
"After The Fire"; The Legacy of College Dormitory Fire Twenty Years Later.

Burns : journal of the International Society for Burn Injuries

Conlon KM, Dimler M, Petrone S, Marano M.
PMID: 34903401
Burns. 2021 Nov 18; doi: 10.1016/j.burns.2021.10.016. Epub 2021 Nov 18.

In January of 2000 the team at The Burn Center at Saint Barnabas was confronted with what is to date, the single largest burn mass casualty incident since its doors opened in 1977. Looking back through history at other...

Cite
Conlon KM, Dimler M, Petrone S, et al. "After The Fire"; The Legacy of College Dormitory Fire Twenty Years Later. Burns. 2021;doi: 10.1016/j.burns.2021.10.016.
Conlon, K. M., Dimler, M., Petrone, S., & Marano, M. (2021). "After The Fire"; The Legacy of College Dormitory Fire Twenty Years Later. Burns : journal of the International Society for Burn Injuries, . https://doi.org/10.1016/j.burns.2021.10.016
Conlon, Kathe M, et al. ""After The Fire"; The Legacy of College Dormitory Fire Twenty Years Later." Burns : journal of the International Society for Burn Injuries vol. (2021). doi: https://doi.org/10.1016/j.burns.2021.10.016
Conlon KM, Dimler M, Petrone S, Marano M. "After The Fire"; The Legacy of College Dormitory Fire Twenty Years Later. Burns. 2021 Nov 18; doi: 10.1016/j.burns.2021.10.016. Epub 2021 Nov 18. PMID: 34903401.
Copy Download .nbib Format: NLM
Effectiveness of a Science Agricultural Summer Experience (SASE) in Recruiting Students to Natural Resources Management.

Martinez E, Lindline J, Petronis MS, Pilotti M.
UIID-AD: 1096
2012;21:713-721. doi: 10.1007/s10956-011-9359-3.

The Bureau of Labor Statistics projects an increase in Natural Resource Management (NRM) jobs within the next 10 years due to baby-boomer retirements and a 12% increase in demand for these occupations. Despite this trend, college enrollment in NRM...

Cite
Martinez E, Lindline J, Petronis MS, et al. Effectiveness of a Science Agricultural Summer Experience (SASE) in Recruiting Students to Natural Resources Management. 2012;21:713-721doi: 10.1007/s10956-011-9359-3.
Martinez, E., Lindline, J., Petronis, M. S., & Pilotti, M. (2012). Effectiveness of a Science Agricultural Summer Experience (SASE) in Recruiting Students to Natural Resources Management. 21713-721. https://doi.org/10.1007/s10956-011-9359-3
Martinez, E, et al. "Effectiveness of a Science Agricultural Summer Experience (SASE) in Recruiting Students to Natural Resources Management." vol. 21 (2012): 713-721. doi: https://doi.org/10.1007/s10956-011-9359-3
Martinez E, Lindline J, Petronis MS, Pilotti M. Effectiveness of a Science Agricultural Summer Experience (SASE) in Recruiting Students to Natural Resources Management. 2012;21:713-721. doi: 10.1007/s10956-011-9359-3. UIID-AD: 1096.
Copy Download .nbib Format: NLM
Showing 325 to 332 of 332 entries